Thursday, March 16, 2023 Daily Archives

Digitalized platform aims to help Bayer exceed in CGT space

by

Bayer says ‘Biotech Data as a Service (BDAS),’ a digitalized platform under development, will further its position in the cell and gene therapy space. Earlier this year, biopharma firm Bayer struck a $40 million deal with Mammoth Biosciences to access CRISPR systems for the development of in vivo gene-editing therapies. The collaboration is the latest in a string of investments in the cell and gene therapy (CGT) sector, a sector described by Bayer’s VP of Biotech Data Science & Digitalization Oliver Hesse…

March 16, 2023

Thermo Fisher cutting jobs at single-use sites in Utah

by

Despite recent expansions at its single-use technology (SUT) production facilities in Utah, Thermo Fisher is preparing to lay-off staff due to “macro-economic conditions.” Bioprocess vendor Thermo Fisher has seen a string of investments across its global production network. In Utah, specifically, the firm expanded capacity at a BioProcess Container (BPC) facility in Logan in late 2020, and – just last year – opened a 55,000 square-foot single-use technology (SUT) facility in Ogden. While the latter expansion saw Thermo Fisher hire…

March 16, 2023